Observational studyInternational journal of hematology2019

Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system.

Masahiro Kizaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.